Avestar Capital LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Avestar Capital LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,971 shares of the medical equipment provider’s stock after purchasing an additional 296 shares during the quarter. Avestar Capital LLC’s holdings in Intuitive Surgical were worth $2,595,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $82,517,000. Sycomore Asset Management grew its stake in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC increased its holdings in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on ISRG shares. Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Truist Financial increased their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Wells Fargo & Company increased their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $589.61 on Thursday. The stock has a market capitalization of $210.01 billion, a P/E ratio of 91.98, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a 50 day moving average price of $557.70 and a 200 day moving average price of $517.49.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.